US OptionsDetailed Quotes

CSL250117C600000

Watchlist

0.45
0.000.00%

15min DelayClose Jan 3 16:00 ET

0.00High0.00Low

Carlisle Companies Stock Discussion

WeiTheSaint469

Jun 7, 2024 14:37

company will go down and up alot soon.

$Carlisle Companies (CSL.US)$

Moomoo AI

Feb 29, 2024 10:27

The share price has tracked EPS growth, suggesting market sentiment towards the shares remains steady. The stock's recent performance has improved, with a better one-year total shareholder return than the five-year return. Dividends have enhanced the total shareholder return.

Those Who Invested in Carlisle Companies (NYSE:CSL) Five Years Ago Are up 202%

Moomoo AI

Feb 13, 2024 01:07

CSL anticipates robust annualized double-digit earnings growth over the medium term, driven by strong patient demand for its immunoglobulins franchise. The company has bounced back from the pandemic's impact on its blood plasma collections.

CSL Says 1H Profit Rises, Boosts Dividend

Moomoo AI

Jan 30, 2024 08:29

The positive trends in Carlisle Companies' ROCE and its ability to consistently reinvest in itself make it an attractive investment. Investors are expecting more growth in the future. However, it's important to check if these trends will continue.

There's Been No Shortage Of Growth Recently For Carlisle Companies' (NYSE:CSL) Returns On Capital

Moomoo AI

Dec 5, 2023 08:47

The stock is seen as overpriced by valuation models, making it less attractive for purchase. With the company's low likelihood of significant earnings growth, its investment appeal is diminished. Profits could be made if share prices meet realistic values.

Should You Think About Buying Carlisle Companies Incorporated (NYSE:CSL) Now?

Moomoo AI

Nov 21, 2023 11:13

Carlisle Companies' growth is praised, but future performance remains key. Dividends have boosted total shareholder return, despite short-term performance being below market. Effective business strategy is expected to continue but investors should note identified risks.

Investors in Carlisle Companies (NYSE:CSL) Have Seen Stellar Returns of 180% Over the Past Five Years

Moomoo AI

Nov 8, 2023 06:32

Despite no insider trades recently at Carlisle Companies, management's considerable stock ownership aligns their interests with shareholders'. Yet, no insider buying in the last year is concerning.

Carlisle Companies Insiders Sell US$3.1m Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 16, 2023 02:33

This downgrade hints at a downturn in business conditions for Carlisle Companies, suggesting worse than industry performance and potential market caution. The downgrade may increase the company's debt pressure, hinting at possible fiscal tightening.

Newsflash: Carlisle Companies Incorporated (NYSE:CSL) Analysts Have Been Trimming Their Revenue Forecasts

Mooers Radar

Oct 31, 2022 04:25

Columns US Top Gap Ups and Downs on 10/28: PINS, TMUS, AMZN, JD and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $DexCom (DXCM.US)$ - up 6.43%
2. $Arch Capital (ACGL.US)$ - up 6.26%
3. $Pinterest (PINS.US)$ - up 5.32%
4. $Gilead Sciences (GILD.US)$ - up 3.83%
5. $VeriSign (VRSN.US)$ - up 3.65%
6. $T-Mobile US (TMUS.US)$ - up 3.05%
7. $Arthur J. Gallagher (AJG.US)$ - up 2.11%
8. $nVent Electric (NVT.US)$ - 2.09%...

+17

Analysts Notebook

Apr 5, 2022 05:45

Columns Top upgrades and downgrades on 4/5

Upgrades
• $Clean Harbors (CLH.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $120
• $EZCORP (EZPW.US)$ : Jefferies Upgrades to Buy From Hold - PT $8.50
• $First Republic Bank (FRC.US)$ : Credit Suisse Upgrades to Neutral From Underperform - PT $187
• $Generac (GNRC.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $410
• $Teva Pharmaceutical Industries (TEVA.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $13 (from $11)
• $Xylem (XYL.US)$ ...

No comment yet